162 related articles for article (PubMed ID: 36517903)
1. Assessing the health risk of living near composting facilities on lung health, fungal and bacterial disease in cystic fibrosis: a UK CF Registry study.
Khan MS; Douglas P; Hansell AL; Simmonds NJ; Piel FB
Environ Health; 2022 Dec; 21(1):130. PubMed ID: 36517903
[TBL] [Abstract][Full Text] [Related]
2. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
3. [Italian Cystic Fibrosis Registry (ICFR). Report 2021-2022].
Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2024; 48(2 Suppl 2):1-41. PubMed ID: 38742380
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of Pseudomonas and Aspergillus co-infected cystic fibrosis patients: A UK registry study.
Hughes DA; Archangelidi O; Coates M; Armstrong-James D; Elborn SJ; Carr SB; Davies JC
J Cyst Fibros; 2022 Jan; 21(1):129-135. PubMed ID: 33958279
[TBL] [Abstract][Full Text] [Related]
5. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P
BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569
[TBL] [Abstract][Full Text] [Related]
6. A multinational report on SARS-CoV-2 infection outcomes in people with CF and Aspergillus infection or ABPA.
Bradbury JD; Chesshyre E; Orenti A; Jung A; Warris A;
J Cyst Fibros; 2024 Mar; 23(2):354-363. PubMed ID: 37925255
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for Pseudomonas aeruginosa airway infection and lung function decline in children with cystic fibrosis.
Mésinèle J; Ruffin M; Kemgang A; Guillot L; Boëlle PY; Corvol H
J Cyst Fibros; 2022 Jan; 21(1):45-51. PubMed ID: 34629287
[TBL] [Abstract][Full Text] [Related]
8. The impact of switching to race-neutral reference equations on FEV
Rosenfeld M; Cromwell EA; Schechter MS; Ren C; Flume PA; Szczesniak RD; Morgan WJ; Jain R
J Cyst Fibros; 2024 May; 23(3):443-449. PubMed ID: 38556415
[TBL] [Abstract][Full Text] [Related]
9. Disease burden in people with cystic fibrosis heterozygous for F508del and a minimal function mutation.
Sawicki GS; Van Brunt K; Booth J; Bailey E; Millar SJ; Konstan MW; Flume PA
J Cyst Fibros; 2022 Jan; 21(1):96-103. PubMed ID: 34289939
[TBL] [Abstract][Full Text] [Related]
10. Patients with cystic fibrosis and advanced lung disease benefit from lumacaftor/ivacaftor treatment.
Ejiofor LCK; Mathiesen IHM; Jensen-Fangel S; Olesen HV; Skov M; Philipsen LKD; Pedersen CL; Pressler T
Pediatr Pulmonol; 2020 Dec; 55(12):3364-3370. PubMed ID: 32897653
[TBL] [Abstract][Full Text] [Related]
11. Average rate of lung function decline in adults with cystic fibrosis in the United Kingdom: Data from the UK CF registry.
Caley L; Smith L; White H; Peckham DG
J Cyst Fibros; 2021 Jan; 20(1):86-90. PubMed ID: 32381400
[TBL] [Abstract][Full Text] [Related]
12. Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation.
Mondejar-Lopez P; Zolin A; Garcia-Marcos PW; Pastor-Vivero MD; Rosa-Silvestre M; de Asis Sanchez-Martinez F; Salvatore D; Cimino G; Majo F; Sole-Jover A; Asensio de la Cruz O; Calderazzo MA; Pizzamiglio G; Castillo-Corullon S; Alvarez-Fernandez A; Gartner S; Padoan R; Carnovale V; Salvatore M; Moya-Quiles MR; Orenti A; Glover G; Sanchez-Solis M
Respir Med; 2022 Feb; 192():106736. PubMed ID: 35032736
[TBL] [Abstract][Full Text] [Related]
13. Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: A longitudinal study using UK patient registry data.
Keogh RH; Szczesniak R; Taylor-Robinson D; Bilton D
J Cyst Fibros; 2018 Mar; 17(2):218-227. PubMed ID: 29311001
[TBL] [Abstract][Full Text] [Related]
14. A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function.
Al Shakirchi M; Klingspor L; Bergman P; Hjelte L; de Monestrol I
Int J Infect Dis; 2020 Jul; 96():663-670. PubMed ID: 32450290
[TBL] [Abstract][Full Text] [Related]
15. [Italian Cystic Fibrosis Registry (ICFR). Report 2017-2018].
Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2021; 45(3 Suppl 1):1-37. PubMed ID: 34132083
[TBL] [Abstract][Full Text] [Related]
16. Changes in Care during the COVID-19 Pandemic for People with Cystic Fibrosis.
Sanders DB; Wu R; O'Neil T; Elbert A; Petren K; Jain R; Ren CL
Ann Am Thorac Soc; 2022 Oct; 19(10):1697-1703. PubMed ID: 35143374
[No Abstract] [Full Text] [Related]
17. Association Between Number of Intravenous Antipseudomonal Antibiotics and Clinical Outcomes of Pediatric Cystic Fibrosis Pulmonary Exacerbations.
Cogen JD; Faino AV; Onchiri F; Hoffman LR; Kronman MP; Nichols DP; Rosenfeld M; Gibson RL
Clin Infect Dis; 2021 Nov; 73(9):1589-1596. PubMed ID: 34100912
[TBL] [Abstract][Full Text] [Related]
18. [Italian Cystic Fibrosis Registry (ICFR). Report 2019-2020].
Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2022; 46(4 Suppl 2):1-38. PubMed ID: 36102313
[TBL] [Abstract][Full Text] [Related]
19. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
20. Lung function in children with cystic fibrosis in the USA and UK: a comparative longitudinal analysis of national registry data.
Schlüter DK; Ostrenga JS; Carr SB; Fink AK; Faro A; Szczesniak RD; Keogh RH; Charman SC; Marshall BC; Goss CH; Taylor-Robinson D
Thorax; 2022 Feb; 77(2):136-142. PubMed ID: 33975926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
